Morning Briefing
Summaries of health policy coverage from major news organizations
Nature News Examines Meningitis Vaccine Program To Roll Out In Africa
Nature News reports on an immunization campaign kicking off in Africa in December that will offer protection to some areas of Africa's meningitis belt. "Millions will receive a new vaccine, MenAfriVac, that promises protection against the meningococcal bacterium Neisseria meningitides," the news service writes, noting the effort "is the culmination of ten years' work by an international consortium to develop a vaccine at a price low enough for massive use in Africa: just US$0.40 a dose."
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
